Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additional DPT booster in children previously vaccinated with DPT-IPV-Hib or DPT-IPV
jRCTs071250107Active, not recruiting
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in diphtheria, pertussis and Tetanus, sponsored by Research Foundation for Microbial Diseases of Osaka University. Started Dec 2025; status: active, not recruiting.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
diphtheriapertussisTetanus
Beyond the preview
Go deeper on jRCTs071250107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071250107.